Patent · US Active

Universal Sanger sequencing from next-gen sequencing amplicons

US11085079B2 · kind B2 · utility

1Cited by

0References

14Claims

0Family size

Assignee

Quest Diagnostics Investments LLC · US

Inventors

Heather R. Sanders · Olivehurst, US
Hai-Rong Li · Mission Viejo, US
Feras Hantash · San Juan Capistrano, US
Frederic Waldman · San Francisco, US

Key dates

Filing date	Oct 26, 2018
Grant date	Aug 10, 2021
Priority date	—
Expiry date	Jun 6, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/16
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.